Definitive Healthcare Corp. Receives “Hold” Rating from Analysts

Definitive Healthcare Corp. (NASDAQ: DH) has received a consensus rating of “Hold” from nine research firms currently covering the company, according to a report by Marketbeat. The analysis indicates a mixed outlook, with two analysts assigning a sell rating, five issuing a hold rating, one giving a buy rating, and another providing a strong buy rating.

The average twelve-month price target among these brokerages stands at approximately $4.19. Several research reports have recently addressed the company’s stock performance. Notably, on November 10, Canaccord Genuity Group reduced its price target for Definitive Healthcare from $5.00 to $4.00, maintaining a “hold” rating. Meanwhile, Barclays lowered its target price from $3.00 to $2.75 and assigned an “underweight” rating on December 8.

In a different assessment, Weiss Ratings reaffirmed a “sell (D-)” rating on October 8, while William Blair upgraded its rating to “strong buy” on November 6.

Quarterly Performance and Future Guidance

Definitive Healthcare released its quarterly earnings data on November 6, reporting earnings per share of $0.07, exceeding analysts’ expectations of $0.06. The company also reported a revenue of $60.05 million, surpassing the anticipated $59.51 million. Despite these positive indicators, the firm recorded a negative net margin of 77.88% and a modest return on equity of 3.30%.

Looking ahead, Definitive Healthcare has set its fiscal year 2025 guidance at earnings per share between $0.230 and $0.240, with a fourth-quarter guidance of $0.050 to $0.060 per share. Analysts predict an average earnings per share of $0.16 for the current fiscal year.

Changes in Institutional Investment

Institutional investors have also been active in modifying their positions in Definitive Healthcare. Notably, Goldman Sachs Group Inc. increased its stake by an impressive 564.2% during the first quarter, now holding 8,716,725 shares valued at $25.19 million after acquiring an additional 7,404,363 shares.

Other significant movements include Arrowstreet Capital Limited Partnership, which acquired a new stake valued at approximately $4.25 million in the second quarter, and Whetstone Capital Advisors LLC, which invested approximately $2.51 million in a new position during the first quarter. Additionally, Jane Street Group LLC expanded its holdings by 212.4% in the second quarter, now owning 328,410 shares worth $1.28 million.

Overall, approximately 98.67% of Definitive Healthcare’s stock is owned by institutional investors and hedge funds, indicating strong confidence in the company’s potential.

Founded in the United States, Definitive Healthcare Corp. provides a software-as-a-service (SaaS) healthcare commercial intelligence platform. This platform offers valuable insights into healthcare providers and their activities, assisting clients in various aspects from product development to market strategies.